Literature DB >> 26674799

Can Erectile Dysfunction in Young Patients Serve as a Surrogate Marker for Coronary Artery Disease?

Kaje Yogesh Dattatrya1, Tanwar Harshawardhan Vedpalsingh1, Wagaska Vinayak Gorakhnath1, Patwardhan Sujata Kiran2.   

Abstract

INTRODUCTION: Early diagnosis and expeditious management of coronary artery disease (CAD) has a rewarding survival benefit. AIM: To study whether erectile dysfunction (ED) serves as a surrogate marker for CAD in a young patient. SETTINGS AND
DESIGN: Males (n=207) between ages 20-60 years with ED were evaluated prospectively for risk factors for CAD.
MATERIALS AND METHODS: Blood Glucose Levels (BGL) fasting and post meal), lipid profile (LP) and 12 lead electrocardiogram (ECG) was done in all of them. International Index of Erectile Function-5 (IEF-5) was used for the evaluation of ED. Those with abnormal parameters were assessed by cardiologists by echocardiography, stress test and if necessary coronary angiography (Non-Invasive or Invasive). STATISTICAL ANALYSIS: All the data were analysed using SPSS. 16 statistical software (SPSS Inc., Chicago, IL, USA). All data are expressed as mean and standard deviation. The Student's t-test was used to compare means between groups, and the chi-square test was used to compare proportions between the groups. P-value <0.05 was considered statistically significant. All confidence intervals (CIs) are two tailed and calculated at the 0.05 level.
RESULTS: Out of 207, 149 patients had at least one abnormal screening parameter. All underwent cardiology consultation and 2D ECHO and Stress test. Thirty six patients underwent coronary angiography. CAD was found in 22 patients. Of these, 19 patients had severe ED. Nine patients were between 20-40 years of age (13.23%). All 9 young patients had deranged LP; severe ED. Six patients were smokers while nobody was hypertensive.
CONCLUSION: ED serves as a surrogate marker for CAD in young patients (p=0.001). Presence of risk factors and lab abnormalities in young patients with ED warrants a cardiology referral to detect CAD.

Entities:  

Keywords:  Coronary angiography; International Index of Erectile Function-5 (IEF-5); Smokers

Year:  2015        PMID: 26674799      PMCID: PMC4668461          DOI: 10.7860/JCDR/2015/14207.6709

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  22 in total

Review 1.  Erectile dysfunction.

Authors:  T F Lue
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

2.  Relation of erectile dysfunction to angiographic coronary artery disease.

Authors:  Hemant Solomon; Jonathan W Man; Anthony S Wierzbicki; Graham Jackson
Journal:  Am J Cardiol       Date:  2003-01-15       Impact factor: 2.778

3.  Prediction of cardiovascular events with aortic stiffness in patients with erectile dysfunction.

Authors:  Charalambos Vlachopoulos; Nikolaos Ioakeimidis; Konstantinos Aznaouridis; Dimitrios Terentes-Printzios; Konstantinos Rokkas; Athanasios Aggelis; Dimosthenis Panagiotakos; Christodoulos Stefanadis
Journal:  Hypertension       Date:  2014-06-30       Impact factor: 10.190

4.  Erectile dysfunction precedes and is associated with severity of coronary artery disease among Asian Indians.

Authors:  Jatinder Kumar; Tanuj Bhatia; Aditya Kapoor; Priyadarshi Ranjan; Aneesh Srivastava; Archana Sinha; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Rakesh Kapoor; Pravin K Goel
Journal:  J Sex Med       Date:  2013-01-24       Impact factor: 3.802

Review 5.  The epidemiology of erectile dysfunction and its risk factors.

Authors:  A Bortolotti; F Parazzini; E Colli; M Landoni
Journal:  Int J Androl       Date:  1997-12

6.  Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus.

Authors:  G Jackson; N Boon; I Eardley; M Kirby; J Dean; G Hackett; P Montorsi; F Montorsi; C Vlachopoulos; R Kloner; I Sharlip; M Miner
Journal:  Int J Clin Pract       Date:  2010-06       Impact factor: 2.503

7.  Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension.

Authors:  M Burchardt; T Burchardt; A G Anastasiadis; A J Kiss; A Shabsigh; A de La Taille; R V Pawar; L Baer; R Shabsigh
Journal:  Int J Impot Res       Date:  2001-10       Impact factor: 2.896

8.  Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease.

Authors:  Francesco Montorsi; Alberto Briganti; Andrea Salonia; Patrizio Rigatti; Alberto Margonato; Andrea Macchi; Stefano Galli; Paolo M Ravagnani; Piero Montorsi
Journal:  Eur Urol       Date:  2003-09       Impact factor: 20.096

9.  Sexual dysfunction in stroke patients.

Authors:  J T Korpelainen; M L Kauhanen; H Kemola; U Malinen; V V Myllylä
Journal:  Acta Neurol Scand       Date:  1998-12       Impact factor: 3.209

10.  Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men.

Authors:  R Virag; P Bouilly; D Frydman
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

View more
  4 in total

1.  Heart Rate Variability and Erectile Function in Younger Men: A Pilot Study.

Authors:  Rui Miguel Costa; Paula Mangia; José Pestana; David Costa
Journal:  Appl Psychophysiol Biofeedback       Date:  2021-01-02

Review 2.  Erectile dysfunction therapy in countries where implant is economically not feasible.

Authors:  Adrián M Garza-Gangemi; Mariano Sotomayor-de Zavaleta
Journal:  Transl Androl Urol       Date:  2017-04

3.  Erectile dysfunction is associated with subclinical carotid vascular disease in young men lacking widely-known risk factors.

Authors:  Feng-Juan Yao; Ya-Dong Zhang; Zi Wan; Wei Li; Hong Lin; Chun-Hua Deng; Yan Zhang
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

4.  Detection of Coronary Artery Disease by an Erectile Dysfunction Questionnaire.

Authors:  Mehrab Sayadi; Reza Elmafshar; Iman Razeghian-Jahromi; Mohammad Javad Zibaeenezhad
Journal:  Cardiol Res Pract       Date:  2021-03-13       Impact factor: 1.990

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.